combination therapy (Belina Pharma)

N/A

Report date: 2025/01/26 19:11:30
NME

Base Information

Drug Namecombination therapy (Belina Pharma)
Drug Alias Namecombination therapy (Belina Pharma/LIDDS)NZ-Belinacombination therapy (Belina Pharma/LIDDS)
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBelina Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesBelina Pharma Ab
Inactive CompaniesLidds Ab
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A